Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV002211367 | SCV002497945 | uncertain significance | not provided | 2022-01-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002481027 | SCV002783058 | uncertain significance | Familial cold autoinflammatory syndrome 3; Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation | 2021-11-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003089122 | SCV002930817 | uncertain significance | Familial cold autoinflammatory syndrome 3 | 2024-01-09 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 1127 of the PLCG2 protein (p.Pro1127Ala). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with PLCG2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1675638). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |